GR20180100568A - Ditanny-based composition against acanthamoeba bacterium affecting the eyes - Google Patents
Ditanny-based composition against acanthamoeba bacterium affecting the eyes Download PDFInfo
- Publication number
- GR20180100568A GR20180100568A GR20180100568A GR20180100568A GR20180100568A GR 20180100568 A GR20180100568 A GR 20180100568A GR 20180100568 A GR20180100568 A GR 20180100568A GR 20180100568 A GR20180100568 A GR 20180100568A GR 20180100568 A GR20180100568 A GR 20180100568A
- Authority
- GR
- Greece
- Prior art keywords
- ditanny
- acanthamoeba
- bacterium
- solution
- eyes
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 11
- 241000224422 Acanthamoeba Species 0.000 title claims abstract description 8
- 241000894006 Bacteria Species 0.000 title claims description 6
- 238000012423 maintenance Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 abstract description 7
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 2
- 239000012467 final product Substances 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 239000002997 ophthalmic solution Substances 0.000 abstract 1
- 229940054534 ophthalmic solution Drugs 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 5
- 241000224423 Acanthamoeba castellanii Species 0.000 description 2
- 241000224430 Acanthamoeba polyphaga Species 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000006479 glucose peptone medium Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003812 trophozoite Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/22—Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Σύνθεση με βάση το Δίκταμο κατά του βακτηρίου Ακανθαμοέμπα που προσβάλει τους οφθαλμούς Composition based on Dictam against the bacterium Acanthamoeba that affects the eyes
Περιγραφή Description
Η σύνθεση μας βασίζεται στο Βότανο Δίκταμο το οποίο μετά από κατάλληλη επεξεργασία αναμιγνύεται με διάλυμα φύλαξης/συντήρησης φακών επαφής για την τελική μορφή του. Our formulation is based on the Dictamos Herb which, after appropriate treatment, is mixed with a contact lens storage/maintenance solution for its final form.
Το μικρόβιο Acanthamoeba είναι πολύ επικίνδυνο όταν προσβάλει τους οφθαλμούς προκαλεί λοίμωξη και μπορεί να προκαλέσει ακόμα και τύφλωση. Εμφανίζεται κυρίως σε φακούς επαφής και στους χώρους (κασετίνες) αποθήκευσης/συντήρησης αυτών. Η θεραπεία είναι δύσκολη και με άγνωστο ποσοστό επιτυχίας. The microbe Acanthamoeba is very dangerous when it infects the eyes it causes infection and can even cause blindness. It mainly appears in contact lenses and in their storage/maintenance areas (cases). Treatment is difficult and with an unknown success rate.
Πλεονέκτημα της εφεύρεσής μας είναι ότι η σύνθεσή μας δεν είναι χημική και δεν περιέχει φάρμακα, καθώς βασίζεται σε ένα βότανο που αναπτύσσεται σε βουνά της Κρήτης και έχει αποδεδειγμένα αποτελέσματα εξουδετέρωσης του μικροβίου, μετά από πειράματα σε εργαστήρια στην Σκωτία. The advantage of our invention is that our composition is not chemical and does not contain drugs, as it is based on an herb that grows in the mountains of Crete and has proven effects of neutralizing the microbe, after experiments in laboratories in Scotland.
Στο Σχήμα 1, αναφέρεται η μέθοδος και το αποτέλεσμα της μελέτης από Πανεπιστήμιο Σκωτίας, σχετικά με την αντιμετώπιση του βακτηρίου. In Figure 1, the method and the result of the study by the University of Scotland, regarding the treatment of the bacterium, is reported.
Χρησιμοποίησαν 2 τύπους του βακτηρίου (Acanthamoeba castellanii(70) και Acanthamoeba polYphaga(71)) με 5 εκχυλίσματα από Dictamo σε μια συγκέντρωση αποθεμάτων 100 mg/ml αντίστοιχα σε Dimethyl Sulfoxide. Τα φάρμακα αραιώθηκαν και χρησιμοποιήθηκαν για την ανίχνευση των 2 τύπων Acanthamoeba. 10 διπλές αραιώσεις έκαστου κλάσματος παρασκευάστηκαν εις τριπλούν διαμέσου της πλάκας και σε κάθε ένα προστέθηκαν 2χ105 (Α. Castellanii) και 8χ104 (A. Polyphaga) τροφοζωίτες που καλλιεργήθηκαν σε μέσο γλυκόζης Peptone στους 23 βαθμούς C. Οι πλάκες επωάστηκαν για 4 ημέρες και εκτιμήθηκε η βιωσιμότητα με την χρήση της δοκιμασίας Blue alamar(indicator for metabolic cell function). Τελικά αποδείχθηκε ότι το κλάσμα 4(fraction 4) είναι ποιο αποτελεσματικό να εξουδετερώνει τόσο το 70 όσο και το 71. They used 2 types of the bacterium (Acanthamoeba castellanii(70) and Acanthamoeba polYphaga(71)) with 5 extracts from Dictamo at a stock concentration of 100 mg/ml respectively in Dimethyl Sulfoxide. The drugs were diluted and used to detect the 2 types of Acanthamoeba. 10 two-fold dilutions of each fraction were prepared in triplicate across the plate and to each were added 2x105 (A. castellanii) and 8x104 (A. polyphaga) trophozoites cultured in glucose Peptone medium at 23 degrees C. The plates were incubated for 4 days and the viability using the Blue alamar (indicator for metabolic cell function) test. Finally, fraction 4 was shown to be the most effective at neutralizing both 70 and 71.
Σε υγρή μορφή, είναι ιδιαίτερα αποτελεσματική σε αυτούς που φορούν φακούς επαφής ή κολυμπούν σε πισίνες όπου ο κίνδυνος προσβολής είναι πολύ μεγαλύτερος. Για την καταπολέμηση της Acanthamoeba, το μόνο που χρειάζεται είναι η προσθήκη του διαλύματος μας τόσο στους φακούς επαφής όσο και στον χώρο συντήρησης αυτών. Αντιμετώπιση λοιπόν με φυσικό τρόπο, χωρίς παρενέργειες που συνήθως περιέχουν οι φαρμακευτικές αγωγές. Μπορεί να κατασκευαστεί σε διαφορετικές μορφές ανάλογα τις απαιτήσεις του εμπορίου π.χ. κρέμα ή σε διάλυμα υγρής μορφής. In liquid form, it is particularly effective for those who wear contact lenses or swim in pools where the risk of infection is much greater. To combat Acanthamoeba, all that is needed is the addition of our solution to both the contact lenses and the lens storage area. Therefore, treatment in a natural way, without side effects that usually contain pharmaceutical treatments. It can be manufactured in different forms according to the requirements of the trade e.g. cream or liquid solution.
Η εφεύρεση μας με βάση το Βότανο Δίκταμο χαρακτηρίζεται από την ανάμιξη του, τριμμένο σε μορφή σκόνης, με διάλυμα φύλαξης/συντήρησης φακών επαφής, σε αναλογία lmg σε 2 ml διάλυμα με 5% ποσοστό αυξομείωσης του βοτάνου με περίπου την ίδια αποτελεσματικότητα. Our invention based on the Dictamo herb is characterized by mixing it, ground into a powder form, with a contact lens storage/maintenance solution, in a proportion of lmg in 2 ml solution with a 5% percentage of the herb with approximately the same effectiveness.
Για ιδανική σύνθεση, προσθέτουμε 5mg Δίκταμο σε μορφή σκόνης σε 10ml διάλυμα φύλαξης/συντήρησης φακών επαφής και αναμιγνύουμε για το τελικό προϊόν. For an ideal formulation, add 5mg of Dictam in powder form to 10ml of contact lens storage/maintenance solution and mix for the final product.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20180100568A GR20180100568A (en) | 2018-12-27 | 2018-12-27 | Ditanny-based composition against acanthamoeba bacterium affecting the eyes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20180100568A GR20180100568A (en) | 2018-12-27 | 2018-12-27 | Ditanny-based composition against acanthamoeba bacterium affecting the eyes |
Publications (2)
Publication Number | Publication Date |
---|---|
GR1009779B GR1009779B (en) | 2020-07-06 |
GR20180100568A true GR20180100568A (en) | 2020-07-16 |
Family
ID=71658147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20180100568A GR20180100568A (en) | 2018-12-27 | 2018-12-27 | Ditanny-based composition against acanthamoeba bacterium affecting the eyes |
Country Status (1)
Country | Link |
---|---|
GR (1) | GR20180100568A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1089745B1 (en) * | 1998-06-18 | 2004-09-01 | Biotics Research Corporation | Oregano for the treatment of internal parasites and protozoa |
WO2017094508A1 (en) * | 2015-11-30 | 2017-06-08 | ロート製薬株式会社 | Ophthalmic composition |
US9931428B2 (en) * | 2011-06-13 | 2018-04-03 | Oraldent Limited | Ophthalmic compositions |
-
2018
- 2018-12-27 GR GR20180100568A patent/GR20180100568A/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1089745B1 (en) * | 1998-06-18 | 2004-09-01 | Biotics Research Corporation | Oregano for the treatment of internal parasites and protozoa |
US9931428B2 (en) * | 2011-06-13 | 2018-04-03 | Oraldent Limited | Ophthalmic compositions |
WO2017094508A1 (en) * | 2015-11-30 | 2017-06-08 | ロート製薬株式会社 | Ophthalmic composition |
Also Published As
Publication number | Publication date |
---|---|
GR1009779B (en) | 2020-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zakrewsky et al. | Choline and geranate deep eutectic solvent as a broad‐spectrum antiseptic agent for preventive and therapeutic applications | |
Jang et al. | Chlorpyrifos induces NLRP3 inflammasome and pyroptosis/apoptosis via mitochondrial oxidative stress in human keratinocyte HaCaT cells | |
Skeldon et al. | The inflammasomes: molecular effectors of host resistance against bacterial, viral, parasitic, and fungal infections | |
BR112016006048B1 (en) | ANTIMICROBIAL COMPOSITIONS | |
Lam et al. | Interactions of Listeria monocytogenes with the autophagy system of host cells | |
van der Waal et al. | Sodium chloride and potassium sorbate: a synergistic combination against E nterococcus faecalis biofilms: an in vitro study | |
Gupta et al. | Development and characterization of polyphenon 60 and caffeine microemulsion for enhanced antibacterial activity | |
Siddiqui et al. | Antiamoebic properties of salicylic acid-based deep eutectic solvents for the development of contact lens disinfecting solutions against Acanthamoeba | |
GR20180100568A (en) | Ditanny-based composition against acanthamoeba bacterium affecting the eyes | |
Al-Adham et al. | The antimicrobial activity of oil-in-water microemulsions is predicted by their position within the microemulsion stability zone | |
Zhylkibayev et al. | Retinal injury mouse model and pathophysiological assessment of the effect of arsenical vesicants | |
Wylie et al. | Development of a high-level light-activated disinfectant for hard surfaces and medical devices | |
DK173716B1 (en) | Non-pharmaceutical composition containing a surfactant and a fluorine compound | |
US20200315956A1 (en) | Compositions and methods for treating intervertebral discs | |
Popova et al. | Investigation of the Action of the Anolyte after Different Storage Times on the Gram-negative Bacteria | |
US20090028839A1 (en) | Compositions and methods for the prophylaxis and treatment of vaginal infections | |
Dąbrowska et al. | Improved efficacy of eugenol and trans-anethole in combination with octenidine dihydrochloride against Candida albicans and Candida parapsilosis | |
Caires et al. | Photoinactivation of mcr-1 positive Escherichia coli | |
Latifi et al. | Comparing cytotoxicity and efficacy of miltefosine and standard antimicrobial agents against Acanthamoeba trophozoites and cyst forms: An in vitro study | |
Breikaa et al. | Adverse testicular effects of Botox® in mature rats | |
Jakubowski et al. | Sensitivity of antioxidant-deficient yeast Saccharomyces cerevisiae to peroxynitrite and nitric oxide | |
Gore et al. | Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin‐induced miosis and visual impairment in rats | |
De Lima et al. | Influence of photodynamic action on pure and mixed cultures of gram-negative bacteria: related to growth mechanisms | |
Okojie | Biofilm Inhibition & Drug Synthesis | |
RU2664708C1 (en) | Method of destroying and preventing formation of bacterial biofilms by complex of antimicrobial peptides of insects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted |
Effective date: 20200831 |